CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,408 | +24.0% | 11,241 | +42.5% | 0.00% | – |
| Q2 2023 | $106,001 | +102.4% | 7,887 | +149.7% | 0.00% | – |
| Q1 2023 | $52,377 | -9.0% | 3,159 | +2.1% | 0.00% | – |
| Q4 2022 | $57,566 | +59.9% | 3,095 | +11.3% | 0.00% | – |
| Q3 2022 | $36,000 | +1700.0% | 2,780 | +584.7% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 406 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 406 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -99.9% | 406 | -99.8% | 0.00% | -100.0% |
| Q3 2019 | $1,376,000 | +45766.7% | 259,122 | +25812.2% | 0.00% | – |
| Q2 2018 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |